Top Markets
#1 Helium Helium +41.95%
#2 Seeker Seeker +35.56%
#3 TENDIES TENDIES +31.40%
#4 Pons Pons +29.86%
#5 UnifAI Network UnifAI Network +19.14%
#6 Zylo Ecosystem Zylo Ecosystem +16.99%
#7 DAPPOS DAPPOS +16.76%
#8 ZKsync ZKsync +15.63%
#9 Zora Zora +14.87%
#10 pipedog pipedog +14.42%
Coin of the day
Helium Helium
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Climb Bio, Inc. Climb Bio, Inc.

Climb Bio, Inc.

CLYM
Kedudukan dalam Saham #10440
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic... Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
Harga Saham
$14.66
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$839.37M
Perubahan (1 hari)
-2.67%
Perubahan (1 tahun)
557.32%
Negara
US
Perdagangan Climb Bio, Inc. (CLYM)

Kategori

Healthcare
Sejarah hasil dividen untuk Climb Bio, Inc. (CLYM)
Hasil dividen (TTM) bagi Climb Bio, Inc. (simbol saham: CLYM) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Climb Bio, Inc. (CLYM) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH